In this paper by Kirsty Roberts and colleagues (BMJ 2020;368:m322 doi:10.1136/bmj.m322) An error in one of the economic evaluation input parameters estimated, as part of the economic analysis of the HepCATT intervention, has been identified. The adjusted probability of hepatitis C testing among participants in the control group was incorrectly calculated, owing to the incorrect covariate values being used. The corrected annual probability of testing in the control group parameter is 9.7%, rather than 9.18% as originally reported in Table S4 of the supplementary materials. The correction of this error does not change the conclusions of the cost effectiveness of the HepCATT intervention and has a negligible effect on the economic results, with the intervention being marginally more cost effective. The results have been corrected in the online version.
. 2021 May 5;373:n1130. doi: 10.1136/bmj.n1130
Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care
Collection date 2021.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC
BY-NC. No commercial re-use. See rights and permissions. Published by
BMJ.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
PMCID: PMC8097508 PMID: 33952529
This corrects the article "Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care" in volume 368, m322.